Bevacizumab, capecitabine, and oxaliplatin as neoadjuvant therapy for patients with potentially curable metastatic colorectal cancer.

Gruenberger, Brigit; Tamandl, Dietmar; Schueller, Johannes; Scheithauer, Werner; Zielinski, Christoph; Herbst, Friedrich; Gruenberger, Thomas

Gruenberger, Brigit; Tamandl, Dietmar; Schueller, Johannes; Scheithauer, Werner; Zielinski, Christoph; Herbst, Friedrich; Gruenberger, Thomas.

Affiliation

Gruenberger B; Department of of Oncology, Rudolfstiftung Hospital, Vienna, Austria.

J Clin Oncol ; 26(11): 1830-5, 2008 Apr 10.

Article in En | MEDLINE | ID: mdl-18398148

Subject(s)

Antibodies, Monoclonal/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Colorectal Neoplasms/pathology; Deoxycytidine/analogs & derivatives; Fluorouracil/analogs & derivatives; Liver Neoplasms/drug therapy; Liver Neoplasms/secondary; Organoplatinum Compounds/administration & dosage; Antibodies, Monoclonal/adverse effects; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Bevacizumab; Capecitabine; Chemotherapy, Adjuvant; Colorectal Neoplasms/mortality; Deoxycytidine/administration & dosage; Diarrhea/chemically induced; Drug Administration Schedule; Female; Fluorouracil/administration & dosage; Hematologic Diseases/chemically induced; Humans; Infusions, Intravenous; Liver Neoplasms/surgery; Liver Regeneration/drug effects; Male; Middle Aged; Oxaliplatin; Peripheral Nervous System Diseases/chemically induced; Survival Rate

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Organoplatinum Compounds / Colorectal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Deoxycytidine / Fluorouracil / Liver Neoplasms / Antibodies, Monoclonal Type of study: Prognostic_studies Language: En Journal: J Clin Oncol Year: 2008 Type: Article Affiliation country: Austria

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google